BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6444082)

  • 1. [Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases].
    Spasojević M
    Med Arh; 1984; 38(2):83-4. PubMed ID: 6444082
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED; Elamsson K; Elmestedt U
    Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
    Gitsch E; Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI; Barinov AM; Prilepskaia VN
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract]   [Full Text] [Related]  

  • 8. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins.
    Taggart H; Stout RW
    Ir J Med Sci; 1981 Jan; 150(1):13-4. PubMed ID: 7216711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on the ovulation inhibitor Tri-Ervonum following a more-than-1-year administration].
    McBride WG; MacMillan IS; Heber KR
    Fortschr Med; 1975 Sep; 93(27):1295-8. PubMed ID: 1222929
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial carcinoma and oral contraceptive agents.
    Cohen CJ; Deppe G
    Obstet Gynecol; 1977 Apr; 49(4):390-2. PubMed ID: 193073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations of the 4th Work Meeting of the Discussion Group of Zürich].
    Zentralbl Gynakol; 1990; 112(8):517-9. PubMed ID: 2363321
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraception, 1986. Currently available formulations.
    Hale R
    J Reprod Med; 1986 Jun; 31(6 Suppl):557-8. PubMed ID: 3088272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

  • 17. Chinical experience with levonorgestrel and ethinyl estradiol in Beijing.
    Weng LJ; Gu SJ
    Chin Med J (Engl); 1987 Mar; 100(3):219-23. PubMed ID: 3113845
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of addition oral contraceptives in chicks diet.
    Abdelhamid AM; Tag-el-Den TH
    Arch Tierernahr; 1988 Sep; 38(9):757-66. PubMed ID: 3145731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ministat: a new oral contraceptive of the combined type with low estrogen contents].
    Demol R; Fondu F; Thiery M; Van Kets H
    Brux Med; 1979 Apr; 59(4):225-32. PubMed ID: 466535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.